# EDGAR Filing Document

**Accession Number:** 0000885978
**File Stem:** 0000885978-23-000002
**Filing Date:** 2023-1
**Character Count:** 7775
**Document Hash:** 460c7bd3aba8e7de1c6cd954a3c4ce57
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000885978-23-000002.hdr.sgml**: 20230111

**ACCESSION NUMBER**: 0000885978-23-000002

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230111

**ITEM INFORMATION**: Regulation FD Disclosure

**FILED AS OF DATE**: 20230111

**DATE AS OF CHANGE**: 20230111

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** U S PHYSICAL THERAPY INC /NV
- **CENTRAL INDEX KEY:** 0000885978
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-HEALTH SERVICES [8000]
- **IRS NUMBER:** 760364866
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-11151
- **FILM NUMBER:** 23522798

**BUSINESS ADDRESS:**
- **STREET 1:** 1300 WEST SAM HOUSTON PARKWAY
- **STREET 2:** SUITE 300
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77043
- **BUSINESS PHONE:** 7132977000

**MAIL ADDRESS:**
- **STREET 1:** 1300 WEST SAM HOUSTON PARKWAY
- **STREET 2:** SUITE 300
- **CITY:** HOUSTON
- **STATE:** TX
- **ZIP:** 77043

### UNITED STATES

### SECURITIES AND EXCHANGE COMMISSION

#### WASHINGTON, DC 20549

### FORM 8-K
**CURRENT REPORT**

#### Pursuant to Section 13 or 15(d)

#### of the Securities Exchange Act of 1934

#### Date of Report (Date of earliest event reported): January 11, 2023

## U.S. PHYSICAL THERAPY, INC.

#### (Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Nevada** | **001-11151** | **76-0364866** |
| **(State or other jurisdiction**<br> **of incorporation or organization)** | **(Commission**<br> **File Number)** | **(I.R.S. Employer**<br> **Identification No.)** |

---

---

| | |
|:---|:---|
| **1300 WEST SAM HOUSTON PARKWAY,**<br> **SUITE 300, HOUSTON, Texas** | **77043** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

#### Registrant's telephone number, including area code: (713) 297-7000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12(b) under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| Common Stock, $.01 par value | USPH | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

------

#### ITEM 7.01 Regulation FD Disclosure.
On January 11, 2023, U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services (the "Company"), announced that Chris Reading, Chief Executive Officer, and Carey Hendrickson, Chief Financial Officer, will participate in the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023. The presentation will cover an overview of the Company.

A copy of USPh's investor presentation is posted on the Company's website at www.usph.com.

The presentation includes a discussion of Operating Results and Adjusted EBITDA, non-GAAP (generally accepted accounting principles) financial measures. The presentaion also includes reconciliations of those measures to the most directly comparable financial measures calculated and presented in accordance with GAAP.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including the exhibits, shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

A copy of the press release is attached hereto as Exhibit 99.1

------

#### ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

---

| | |
|:---|:---|
| **Exhibits** | **Description of Exhibits** |
| [99.1](ex99-1.htm) | Registrant's Press Release dated January 10, 2023 \* |

---

\* Filed herewith.

#### SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **U.S. PHYSICAL THERAPY, INC.** | **U.S. PHYSICAL THERAPY, INC.** |
| Dated: January 11, 2023<br>| By: | /s/ CAREY HENDRICKSON |
|  |  | Carey Hendrickson<br>|
|  |  | Chief Financial Officer |
|  |  | (duly authorized officer and principal financial and accounting officer) |

---

## Exhibit 99.1

![](logo_usph2020.jpg)

#### <br>

#### CONTACT:
U.S. Physical Therapy, Inc.

Carey Hendrickson, Chief Financial Officer

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Email: Chendrickson@usph.com<br>

Chris Reading, Chief Executive Officer

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(713) 297-7000

Three Part Advisors

Joe Noyons

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(817) 778-8424

### U.S. Physical Therapy to Present at the<br>

### 41st Annual J.P. Morgan Healthcare Conference <br>

### <br>
**Houston, TX, January 11, 2023** – U.S. Physical Therapy, Inc. (NYSE: USPH), a national operator of outpatient physical therapy clinics and provider of industrial injury prevention services (the "Company"), today announced that Chris Reading, Chief Executive Officer, and Carey Hendrickson, Chief Financial Officer, will participate in the 41st Annual J.P. Morgan Healthcare Conference on Thursday, January 12, 2023. The presentation will cover an overview of the Company.<br> A copy of USPh's investor presentation is posted on the Company's website at www.usph.com.<br><u>**About U.S. Physical Therapy, Inc.**</u> <br>Founded in 1990, U.S. Physical Therapy, Inc. operates 640 outpatient physical therapy clinics in 40 states. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically-related injuries and rehabilitation of injured workers. In addition to owning and operating clinics, the Company manages 40 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The Company also has an industrial injury prevention business which provides onsite services for clients' employees including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments. <br>More information about U.S. Physical Therapy, Inc. is available at www.usph.com. The information included on that website is not incorporated into this press release.<br>

### <br>

------